Biora Therapeutics, Inc.
BIORDelisted Jun 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580063
Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Biora Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −6 vs. Q2 2021
- Shares held
- 47.9M
- −7.12M (−12.9%) vs. Q2 2021
- Total value
- $72.8M
- −$123.6M (−62.9%) vs. Q2 2021
- New holders
- 12
- 11 more added
- Sold out
- 18
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 21 | $6.13M |
| Q2 2024 | 29 | $8.07M |
| Q1 2024 | 28 | $13.3M |
| Q4 2023 | 30 | $16.1M |
| Q3 2023 | 25 | $25.9M |
| Q2 2023 | 31 | $13.2M |
| Q1 2023 | 32 | $6.46M |
| Q4 2022 | 48 | $8.68M |
| Q3 2022 | 47 | $24.1M |
| Q2 2022 | 49 | $34.5M |
| Q1 2022 | 55 | $59.2M |
| Q4 2021 | 57 | $101.3M |
| Q3 2021 | 36 | $72.8M |
| Q2 2021 | 42 | $196.5M |
| Q1 2021 | 48 | $205.6M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Biora Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 247 | $0 | 0.00% | −817−76.8% | Reduced |
| Parallax Volatility Advisers, L.P. | 100 | $0 | 0.00% | +100 | New |
| CIBC Private Wealth Group, LLC | 10,000 | $15.0K | 0.00% | +10,000 | New |
| LPL Financial LLC | 11,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| Cetera Advisors LLC | 12,000 | $18.0K | 0.00% | +12,000 | New |
| Manufacturers Life Insurance Company, The | 13,396 | $20.0K | 0.00% | +13,396 | New |
| Schonfeld Strategic Advisors LLC | 12,900 | $20.0K | 0.00% | +12,900 | New |
| Bank of New York Mellon Corp | 14,039 | $21.0K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 14,150 | $22.0K | 0.00% | +14,150 | New |
| Steward Partners Investment Advisory, LLC | 15,000 | $23.0K | 0.00% | +15,000 | New |
| Eagle Asset Management Inc | 15,935 | $24.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,665 | $24.0K | 0.00% | +3,286+26.5% | Added |
| UBS Group AG | 15,462 | $24.0K | 0.00% | +8,751+130.4% | Added |
| Advisor Group Holdings, Inc. | 17,186 | $26.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 19,059 | $29.0K | 0.01% | −31,727−62.5% | Reduced |
| Wolverine Trading, LLC | 27,217 | $29.0K | 0.00% | +27,217 | New |
| Raymond James & Associates | 22,000 | $33.0K | 0.00% | 00.0% | Unchanged |
| Leonard Rickey Investment Advisors P.L.L.C. | 21,850 | $33.0K | 0.01% | +1,000+4.8% | Added |
| Millennium Management LLC | 28,834 | $44.0K | 0.00% | −97,444−77.2% | Reduced |
| Northern Trust Corp | 36,514 | $56.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 37,802 | $57.0K | 0.00% | +5,334+16.4% | Added |
| Morgan Stanley | 44,207 | $68.0K | 0.00% | −6,521−12.9% | Reduced |
| Jane Street Group, LLC | 62,328 | $95.0K | 0.00% | +62,328 | New |
| Sassicaia Capital Advisers LLC | 67,000 | $102.0K | 0.29% | +67,000 | New |
| Group One Trading, L.P. | 84,909 | $129.0K | 0.00% | +56,766+201.7% | Added |
| Susquehanna Fundamental Investments, LLC | 98,400 | $150.0K | 0.00% | +34,500+54.0% | Added |
| State Street Corp | 107,520 | $163.0K | 0.00% | +5,400+5.3% | Added |
| Birchview Capital, LP | 270,000 | $410.0K | 0.28% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 318,308 | $483.0K | 0.00% | +122,531+62.6% | Added |
| BlackRock Inc. | 432,195 | $657.0K | 0.00% | +825+0.2% | Added |
| Gsa Capital Partners LLP | 615,062 | $935.0K | 0.10% | +615,062 | New |
| Susquehanna International Group, LLP | 783,809 | $1.19M | 0.00% | +676,123+627.9% | Added |
| Renaissance Technologies LLC | 814,700 | $1.24M | 0.00% | +814,700 | New |
| Vanguard Group Inc | 926,066 | $1.41M | 0.00% | +16,180+1.8% | Added |
| Neuberger Berman Group LLC | 6,541,060 | $9.94M | 0.01% | 00.0% | Unchanged |
| Athyrium Capital Management, LP | 36,396,907 | $55.3M | 35.09% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −7,597,166−100.0% | Sold out |
| Parian Global Management LP | 0 | $0 | 0.00% | −1,336,398−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −242,109−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −81,700−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −66,100−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −39,104−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −20,307−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −17,971−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −17,347−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −16,412−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −14,907−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −6,587−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −9,206−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −4,381−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −164−100.0% | Sold out |